News

THE most common sustained heart irregularity is atrial fibrillation (A-Fib), where the atria (upper chambers of the heart} ...
PORTSMOUTH, N.H., May 8, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp. (Laborie), a global leader in diagnostic and therapeutic urology, announced the publication of three-year outcomes ...
The results underscore the long-term durability and safety of the Optilume ® Drug-Coated Balloon (DCB) as a minimally invasive treatment for recurrent anterior urethral strictures in men.
Findings Published in Journal of Endourology Support Minimally Invasive Alternative to Repeat Endoscopic Procedures PORTSMOUTH, N.H., May 8, 2025 /PRNewswire/ -- Laborie Medical Technologies Corp.
The results underscore the long-term durability and safety of the Optilume ® Drug-Coated Balloon (DCB) as a minimally invasive treatment for recurrent anterior urethral strictures in men. The study ...
Three-Year Data From ROBUST III Confirms Long-Term Durability Of Optilume® Drug-Coated Balloon For Recurrent Urethral Strictures. Date. 2025-05-08 07:17:17. Share on Facebook; Tweet on Twitter ...
The 80 patients had a mean age of 65 and moderate-size prostates (mean volume 35.9 cc). Baseline IPSS averaged 22.3 (severe), Qmax 10.9 mL/s, and PVR 63.1 mL.
Approved by the US Food and Drug Administration in 2023, the Optilume BPH devices uses balloons to dilate the anterior commissure of the prostate, which connects the two lobes of the gland, ...